Guangzhen Wu

ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 23

Top Venues

Journal of oncology

BioMed research international

Oxidative medicine and cellular longevity

Clinical and translational medicine

First Affiliated Hospital of Dalian Medical University (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

First Affiliated Hospital of Dalian Medical University

China

PHD

Publications

Qifei Wang, Wei Zhang, Xiaochen Qi, Jiayi Li, Yuanxin Liu, Quanlin Li, Yingkun Xu, Guangzhen Wu
The mechanism of liver X receptor regulates the balance of glycoFAsynthesis and cholesterol synthesis in clear cell renal cell carcinoma. Clinical and translational medicine 13 (5) (2023)
Qifei Wang, Wei Zhang, Xiaochen Qi, Jiayi Li, Yuanxin Liu, Quanlin Li, Yingkun Xu, Guangzhen Wu
The mechanism of liver X receptor regulates the balance of glycoFAsynthesis and cholesterol synthesis in clear cell renal cell carcinoma. Clinical and translational medicine 13 (5) (2023)
Jiaao Sun, Feng Chen, Guangzhen Wu
Potential effects of gut microbiota on host cancers: focus on immunity, DNA damage, cellular pathways, and anticancer therapy. The ISME journal (2023)
Qifei Wang, Wei Zhang, Xiaochen Qi, Jiayi Li, Yuanxin Liu, Quanlin Li, Yingkun Xu, Guangzhen Wu
The mechanism of liver X receptor regulates the balance of glycoFAsynthesis and cholesterol synthesis in clear cell renal cell carcinoma. Clinical and translational medicine 13 (5) (2023)
Xiunan Li, Jiayi Li, Leizuo Zhao, Zicheng Wang, Peizhi Zhang, Yingkun Xu, Guangzhen Wu
Comprehensive Multiomics Analysis Reveals Potential Diagnostic and Prognostic Biomarkers in Adrenal Cortical Carcinoma. Computational and mathematical methods in medicine 2022 (2022)
Peizhi Zhang, Yingkun Xu, Shaoan Chen, Zicheng Wang, Leizuo Zhao, Chen Chen, Weiting Kang, Rongyu Han, Jiechuan Qiu, Qingliang Wang, Han Gao, Guangzhen Wu, Qinghua Xia
ARL4C Regulates the Progression of Clear Cell Renal Cell Carcinoma by Affecting the Wnt/ β -Catenin Signaling Pathway. Journal of oncology 2022 (2022)
Guangzhen Wu, Xiaowei Li, Yuanxin Liu, Quanlin Li, Yingkun Xu, Qifei Wang
Study on HOXBs of Clear Cell Renal Cell Carcinoma and Detection of New Molecular Target. Journal of oncology 2021 (2021)
Xiunan Li, Yu Su, Jiayao Zhang, Ye Zhu, Yingkun Xu, Guangzhen Wu
LAPTM5 Plays a Key Role in the Diagnosis and Prognosis of Testicular Germ Cell Tumors. International journal of genomics 2021 (2021)
Guangzhen Wu, Jianyi Li, Yingkun Xu, Xiangyu Che, Feng Chen, Qifei Wang
A New Survival Model Based on ADAMTSs for Prognostic Prediction in Clear Cell Renal Cell Carcinoma. Journal of oncology 2021 (2021)
Yan Zhang, Mingying Chen, Meihong Liu, Yingkun Xu, Guangzhen Wu
Glycolysis-Related Genes Serve as Potential Prognostic Biomarkers in Clear Cell Renal Cell Carcinoma. Oxidative medicine and cellular longevity 2021 (2021)
Yan Zhang, Yao Yao, Xiaochen Qi, Jianyi Li, Meihong Liu, Xiangyu Che, Yingkun Xu, Guangzhen Wu
Identification of a New Prognostic Risk Signature of Clear Cell Renal Cell Carcinoma Based on N6-Methyladenosine RNA Methylation Regulators. Journal of immunology research 2021 (2021)
Xiangyu Che, Xiaochen Qi, Yingkun Xu, Qifei Wang, Guangzhen Wu
Using Genomic and Transcriptome Analyses to Identify the Role of the Oxidative Stress Pathway in Renal Clear Cell Carcinoma and Its Potential Therapeutic Significance. Oxidative medicine and cellular longevity 2021 (2021)
Xiaochen Qi, Xin Lv, Xiaoxi Wang, Zihao Ruan, Peizhi Zhang, Qifei Wang, Yingkun Xu, Guangzhen Wu
A New Survival Model Based on Cholesterol Biosynthesis-Related Genes for Prognostic Prediction in Clear Cell Renal Cell Carcinoma. BioMed research international 2021 (2021)
Xiangyu Che, Xiaochen Qi, Yingkun Xu, Qifei Wang, Guangzhen Wu
Genomic and Transcriptome Analysis to Identify the Role of the mTOR Pathway in Kidney Renal Clear Cell Carcinoma and Its Potential Therapeutic Significance. Oxidative medicine and cellular longevity 2021 (2021)
Ping Wu, Yingkun Xu, Jiayi Li, Xiaowei Li, Peizhi Zhang, Ningke Ruan, Cong Zhang, Panpan Sun, Qifei Wang, Guangzhen Wu
Comparison of the Fatty Acid Metabolism Pathway in Pan-Renal Cell Carcinoma: Evidence from Bioinformatics. Analytical cellular pathology (Amsterdam) 2021 (2021)
Yingkun Xu, Guangzhen Wu, Jiayao Zhang, Jianyi Li, Ningke Ruan, Jianfeng Zhang, Zhiyu Zhang, Yougen Chen, Qi Zhang, Qinghua Xia
TRIM33 Overexpression Inhibits the Progression of Clear Cell Renal Cell Carcinoma In Vivo and In Vitro. BioMed research international 2020 (2020)
Yingkun Xu, Xiunan Li, Yuqing Han, Zilong Wang, Chenglin Han, Ningke Ruan, Jianyi Li, Xiao Yu, Qinghua Xia, Guangzhen Wu
A New Prognostic Risk Model Based on PPAR Pathway-Related Genes in Kidney Renal Clear Cell Carcinoma. PPAR research 2020 (2020)
Ping Wu, Tingting Xiang, Jing Wang, Run Lv, Guangzhen Wu
TYROBP is a potential prognostic biomarker of clear cell renal cell carcinoma. FEBS open bio 10 (12) (2020)
Guangzhen Wu, Yingkun Xu, Chenglin Han, Zilong Wang, Jiayi Li, Qifei Wang, Xiangyu Che
Identification of a Prognostic Risk Signature of Kidney Renal Clear Cell Carcinoma Based on Regulating the Immune Response Pathway Exploration. Journal of oncology 2020 (2020)
Jianyi Li, Guangzhen Wu, Yingkun Xu, Jiatong Li, Ningke Ruan, Yougen Chen, Qi Zhang, Qinghua Xia
Porcupine Inhibitor LGK974 Downregulates the Wnt Signaling Pathway and Inhibits Clear Cell Renal Cell Carcinoma. BioMed research international 2020 (2020)
Yingkun Xu, Guangzhen Wu, Xue Ma, Jianyi Li, Ningke Ruan, Zhiyu Zhang, Yalei Cao, Yougen Chen, Qi Zhang, Qinghua Xia
Identification of CPT1A as a Prognostic Biomarker and Potential Therapeutic Target for Kidney Renal Clear Cell Carcinoma and Establishment of a Risk Signature of CPT1A-Related Genes. International journal of genomics 2020 (2020)
Yingkun Xu, Guangzhen Wu, Jianyi Li, Jiatong Li, Ningke Ruan, Liye Ma, Xiaoyang Han, Yanjun Wei, Liang Li, Hongge Zhang, Yougen Chen, Qinghua Xia
Screening and Identification of Key Biomarkers for Bladder Cancer: A Study Based on TCGA and GEO Data. BioMed research international 2020 (2020)
Guangzhen Wu, Zhiwei Zhang, Qizhen Tang, Lei Liu, Wei Liu, Quanlin Li, Qifei Wang
Study of FABP's interactome and detecting new molecular targets in clear cell renal cell carcinoma. Journal of cellular physiology 235 (4) (2019)

Guangzhen Wu.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Guangzhen Wu